Abstract High lipoprotein (a)[Lp (a)] concentrations are one of the most important genetically
determined risk factors for cardiovascular disease. Lp (a) concentrations are an enigmatic …

ABSTRACT DNA methylation (DNAm) is one of the most studied epigenetic modifications.
DNAm has emerged as a key biological mechanism and biomarkers to test associations …

Abstract Purpose of Review The purpose of this article is to review current evidence for
lipoprotein (a)(Lp (a)) as a risk factor for multiple cardiovascular (CV) disease phenotypes …

Background and aims High lipoprotein (a)[Lp (a)] concentrations are associated with
increased coronary artery disease (CAD) risk. Lp (a) is regulated mainly genetically by the …

Objective Obesity is a significant public health concern across the globe. Research
investigating epigenetic mechanisms related to obesity and obesity‐associated conditions …

Changes in whole blood DNA methylation levels at several CpG sites have been associated
with circulating blood lipids, specifically high-density lipoprotein and triglycerides. This study …

Abstract Lipoprotein (a)(Lp (a)) is a macromolecular complex consisting of LDL and the
characteristic apolipoprotein (a)(apo (a)). Lp (a) occurs as a quantitative genetic trait with …

In this article, key events of the history of lipoprotein (a)(Lp (a)) research from its discovery as
a genetic trait in human plasma by the Norwegian scientist Kare Berg in 1963 until the …